HZNP insider filings
Horizon Therapeutics Public Ltd Co — 43 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-10-06. Screen HZNP transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for HZNP between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Horizon Therapeutics Public Ltd Co
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-10-06 | 4 | Witz Pascale — Director | Disposition to issuer (D): 25,672 @ $116.50 · Disposition to issuer (D): 20,279 @ $116.50 · Disposition to issuer (D): 52,232 (derivative) · Disposition to issuer (D): 32,161 (derivative) · Disposition to issuer (D): 4,016 (derivative) | EDGAR |
| 2023-10-06 | 4 | Daniel William F — Director | Disposition to issuer (D): 31,915 @ $116.50 · Disposition to issuer (D): 47,670 @ $116.50 · Disposition to issuer (D): 13,286 (derivative) · Disposition to issuer (D): 8,548 (derivative) · Disposition to issuer (D): 23,092 (derivative) · Disposition to issuer (D): 31,153 (derivative) · +2 more | EDGAR |
| 2023-10-06 | 4 | McIlvenny Patrick — Chief Accounting Officer | Disposition to issuer (D): 6,874 @ $116.50 · Disposition to issuer (D): 2,198 (derivative) · Disposition to issuer (D): 3,809 (derivative) · Disposition to issuer (D): 11,498 (derivative) | EDGAR |
| 2023-10-06 | 4 | Pasternak Andy — EVP, Chief Strategy Officer | Disposition to issuer (D): 56,338 @ $116.50 · Disposition to issuer (D): 11,643 (derivative) · Disposition to issuer (D): 15,870 (derivative) · Disposition to issuer (D): 22,997 (derivative) · Disposition to issuer (D): 15,281 (derivative) · Disposition to issuer (D): 5,816 (derivative) · +7 more | EDGAR |
| 2023-10-06 | 4 | Thompson Elizabeth H.Z. — EVP, Research & Development | Disposition to issuer (D): 14,575 @ $116.50 · Disposition to issuer (D): 4,657 (derivative) · Disposition to issuer (D): 14,283 (derivative) · Disposition to issuer (D): 20,697 (derivative) · Disposition to issuer (D): 4,285 (derivative) · Disposition to issuer (D): 12,854 (derivative) · +4 more | EDGAR |
| 2023-10-06 | 4 | Cox Aaron — EVP, Chief Financial Officer | Disposition to issuer (D): 556 @ $116.50 · Disposition to issuer (D): 9,314 (derivative) · Disposition to issuer (D): 15,870 (derivative) · Disposition to issuer (D): 22,997 (derivative) · Disposition to issuer (D): 12,226 (derivative) · Disposition to issuer (D): 4,654 (derivative) · +7 more | EDGAR |
| 2023-10-06 | 4 | DesJardin Michael A. — EVP, Technical Operations | Disposition to issuer (D): 126,838 @ $116.50 · Disposition to issuer (D): 10,479 (derivative) · Disposition to issuer (D): 14,283 (derivative) · Disposition to issuer (D): 20,697 (derivative) · Disposition to issuer (D): 13,753 (derivative) · Disposition to issuer (D): 5,236 (derivative) · +7 more | EDGAR |
| 2023-10-06 | 4 | Clayton Sean M. — EVP, General Counsel | Disposition to issuer (D): 7,655 @ $116.50 · Disposition to issuer (D): 745 @ $116.50 · Disposition to issuer (D): 28,258 (derivative) · Disposition to issuer (D): 22,997 (derivative) · Disposition to issuer (D): 5,749 (derivative) · Disposition to issuer (D): 5,749 (derivative) · +1 more | EDGAR |
| 2023-10-06 | 4 | Shannon James Samuel — Director | Disposition to issuer (D): 33,156 @ $116.50 · Disposition to issuer (D): 23,638 @ $116.50 · Disposition to issuer (D): 8,150 (derivative) · Disposition to issuer (D): 32,161 (derivative) · Disposition to issuer (D): 4,016 (derivative) | EDGAR |
| 2023-10-06 | 4 | Mahony Susan — Director | Disposition to issuer (D): 9,345 @ $116.50 · Disposition to issuer (D): 9,306 @ $116.50 · Disposition to issuer (D): 4,016 (derivative) | EDGAR |
| 2023-10-06 | 4 | Walbert Timothy P — Chairman, President and CEO, Director | Disposition to issuer (D): 616,772 @ $116.50 · Disposition to issuer (D): 107,739 @ $116.50 · Disposition to issuer (D): 100,300 @ $116.50 · Disposition to issuer (D): 49,935 @ $116.50 · Disposition to issuer (D): 742,565 (derivative) · Disposition to issuer (D): 1,650,000 (derivative) · +21 more | EDGAR |
| 2023-10-06 | 4 | Himawan Jeff — Director | Disposition to issuer (D): 44,546 @ $116.50 · Disposition to issuer (D): 36,609 @ $116.50 · Disposition to issuer (D): 7,873 @ $116.50 · Disposition to issuer (D): 23,092 (derivative) · Disposition to issuer (D): 31,153 (derivative) · Disposition to issuer (D): 4,016 (derivative) | EDGAR |
| 2023-10-06 | 4 | Watkins Thomas — Director | Disposition to issuer (D): 110,447 @ $116.50 · Disposition to issuer (D): 55,953 @ $116.50 · Disposition to issuer (D): 10,000 @ $116.50 · Disposition to issuer (D): 8,548 (derivative) · Disposition to issuer (D): 23,092 (derivative) · Disposition to issuer (D): 31,153 (derivative) · +2 more | EDGAR |
| 2023-10-06 | 4 | SANTINI GINO — Director | Disposition to issuer (D): 100,959 @ $116.50 · Disposition to issuer (D): 18,655 @ $116.50 · Disposition to issuer (D): 8,548 (derivative) · Disposition to issuer (D): 31,153 (derivative) · Disposition to issuer (D): 32,161 (derivative) · Disposition to issuer (D): 4,016 (derivative) | EDGAR |
| 2023-10-06 | 4 | GREY MICHAEL G — Director | Disposition to issuer (D): 39,361 @ $116.50 · Disposition to issuer (D): 48,031 @ $116.50 · Disposition to issuer (D): 10,000 @ $116.50 · Disposition to issuer (D): 8,548 (derivative) · Disposition to issuer (D): 23,092 (derivative) · Disposition to issuer (D): 31,153 (derivative) · +2 more | EDGAR |
| 2023-10-06 | 4 | SHERMAN JEFFREY W — EVP and Chief Medical Officer | Disposition to issuer (D): 2,655 @ $116.50 · Disposition to issuer (D): 105,808 @ $116.50 · Disposition to issuer (D): 80,944 @ $116.50 · Disposition to issuer (D): 45,352 @ $116.50 · Disposition to issuer (D): 164,469 (derivative) · Disposition to issuer (D): 9,314 (derivative) · +11 more | EDGAR |
| 2023-10-02 | 4 | Shannon James Samuel — Director | Option exercise (M): 11,850 @ $12.19 · Option exercise (M): 11,850 (derivative) @ $0 | EDGAR |
| 2023-10-02 | 4 | Watkins Thomas — Director | Option exercise (M): 40,000 @ $12.29 · Option exercise (M): 20,000 @ $15.96 · Option exercise (M): 21,323 @ $13.87 · Option exercise (M): 40,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 21,323 (derivative) @ $0 | EDGAR |
| 2023-10-02 | 4 | SANTINI GINO — Director | Option exercise (M): 23,092 @ $15.23 · Option exercise (M): 23,092 (derivative) @ $0 | EDGAR |
| 2023-09-28 | 4 | GREY MICHAEL G — Director | Option exercise (M): 20,000 @ $15.96 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2023-09-27 | 4 | Himawan Jeff — Director | Option exercise (M): 32,161 @ $13.87 · Option exercise (M): 32,161 (derivative) @ $0 | EDGAR |
| 2023-09-25 | 4 | SANTINI GINO — Director | Option exercise (M): 20,000 @ $15.96 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2023-09-07 | 4 | SHERMAN JEFFREY W — EVP and Chief Medical Officer | Gift (G): 2,165 @ $0 | EDGAR |
| 2023-07-28 | 4 | Witz Pascale — Director | Grant/award (A): 4,016 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4 | Daniel William F — Director | Grant/award (A): 4,016 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4 | Shannon James Samuel — Director | Grant/award (A): 4,016 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4 | Mahony Susan — Director | Grant/award (A): 4,016 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4 | Himawan Jeff — Director | Grant/award (A): 4,016 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4 | Watkins Thomas — Director | Grant/award (A): 4,016 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4 | SANTINI GINO — Director | Grant/award (A): 4,016 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4 | GREY MICHAEL G — Director | Grant/award (A): 4,016 (derivative) @ $0 | EDGAR |
| 2023-05-11 | 4 | Himawan Jeff — Director | Gift (G): 7,873 @ $0 · Gift (G): 7,873 @ $0 | EDGAR |
| 2023-05-02 | 4 | Witz Pascale — Director | Option exercise (M): 3,913 · Tax withholding (F): 1,879 @ $111.16 · Option exercise (M): 3,913 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Daniel William F — Director | Option exercise (M): 3,913 · Tax withholding (F): 1,879 @ $111.16 · Option exercise (M): 3,913 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Shannon James Samuel — Director | Option exercise (M): 3,913 · Tax withholding (F): 1,879 @ $111.16 · Option exercise (M): 3,913 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Mahony Susan — Director | Option exercise (M): 3,913 · Tax withholding (F): 1,879 @ $111.16 · Option exercise (M): 3,913 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Himawan Jeff — Director | Option exercise (M): 3,913 · Tax withholding (F): 1,879 @ $111.16 · Option exercise (M): 3,913 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Watkins Thomas — Director | Option exercise (M): 3,913 · Option exercise (M): 3,913 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | SANTINI GINO — Director | Option exercise (M): 3,913 · Option exercise (M): 3,913 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | GREY MICHAEL G — Director | Option exercise (M): 3,913 · Option exercise (M): 3,913 (derivative) @ $0 | EDGAR |
| 2023-03-14 | 4 | Thompson Elizabeth H.Z. — EVP, Research & Development | Gift (G): 2,000 @ $0 | EDGAR |
| 2023-03-06 | 4 | Clayton Sean M. — EVP, General Counsel | Option exercise (M): 14,129 · Tax withholding (F): 7,032 @ $110.34 · Option exercise (M): 14,129 (derivative) @ $0 | EDGAR |
| 2023-03-06 | 4 | DesJardin Michael A. — EVP, Technical Operations | Option exercise (M): 3,629 @ $14.93 · Option exercise (M): 743 @ $17.19 · Option exercise (M): 3,629 (derivative) @ $0 · Option exercise (M): 743 (derivative) @ $0 | EDGAR |
Recent 8-K events — Horizon Therapeutics Public Ltd Co
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-10-06 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-09-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-09-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-09-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-08-08 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-07-28 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-06-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-05-18 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-05-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HZNP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →